Primary Packaging for Sterile Pharmaceutical Products

Primary Packaging for Sterile Pharmaceutical Products

For a sterile medicine, the container is part of the product. A vial, ampoule, prefilled syringe or eye drop bottle does far more than hold the drug. It keeps the product sterile until use, protects it from light, oxygen and moisture, must not react with or leach into the formulation, and must allow the healthcare professional or patient to deliver the correct dose safely. 

Choosing the right primary packaging is therefore a technical and regulatory decision, not just a commercial one. Kilitch Healthcare helps partners select and qualify primary packaging for sterile injectables and ophthalmic products as part of development, technology transfer and manufacturing projects. 

What Primary Packaging Must Do

  • Maintain sterility throughout the shelf life and, for multi-dose products, during use. 
  • Protect the product from light, oxygen, moisture and physical damage. 
  • Remain compatible with the formulation, without unacceptable leaching, adsorption or reaction. 
  • Deliver an accurate dose, whether by syringe, drop or direct injection. 
  • Be safe and practical to handle in hospitals, clinics and homes. 
  • Run reliably on filling lines at commercial speed. 
  • Meet regulatory expectations for the target markets. 

Main Packaging Options for Sterile Products

Container 

Typical products 

Key considerations 

Glass ampoules 

Small-volume single-dose injections 

Glass quality, breakage, glass particles on opening, sealing integrity 

Glass vials with stoppers 

Single- and multi-dose injectables, lyophilised products 

Glass type, stopper material, seal integrity, compatibility 

Prefilled syringes 

Ready-to-use injectable doses 

Barrel material, plunger, siliconisation, needle or luer design 

Multi-dose eye drop bottles 

Preserved ophthalmic solutions and suspensions 

Plastic type, nozzle drop size, preservative compatibility 

Preservative-free multi-dose bottles 

Ophthalmic products without preservatives 

Valve or filter design to prevent contamination 

Unit-dose ophthalmic containers 

Single-use preservative-free eye drops 

Seal integrity, ease of opening, dose volume 

Nasal spray bottles and pumps 

Nasal formulations 

Spray pattern, dose accuracy, pump compatibility 

 Kilitch works with these formats across our sterile injectable, prefilled syringe, ophthalmic and nasal formulation manufacturing. 

Glass Containers for Injectables

Pharmaceutical glass is classified by its chemical resistance. Borosilicate glass is commonly used for injectables because of its strong resistance to chemical attack. Some formulations, especially those with high pH or certain buffers, can interact with glass over time, potentially causing delamination or particles. Selecting the right glass type and supplier, and confirming compatibility through stability studies, helps avoid these issues. 

Glass vials and ampoules are washed and depyrogenated before filling. Their dimensions must be consistent so they run smoothly on filling and sealing equipment. 

Rubber Stoppers and Seals

Stoppers close vials and are pierced by needles during use. They must: 

  • Seal tightly to maintain sterility. 
  • Reseal after needle puncture in multi-dose vials. 
  • Release minimal extractables into the product. 
  • Avoid fragments when pierced. 
  • Withstand sterilisation and, for lyophilised products, allow drying through vented designs. 

Stopper material, coatings and supplier qualification are reviewed for each product. Aluminium or flip-off seals secure the stopper and show evidence of tampering. 

Prefilled Syringes

Prefilled syringes offer convenience and accurate dosing and reduce preparation errors in hospitals. They also bring technical considerations: the barrel material, plunger stopper, lubrication and tip cap can all interact with the product. Break-loose and glide forces must stay within acceptable limits throughout shelf life so the syringe is easy to use. Learn more on our page on prefilled syringe manufacturing. 

Ophthalmic Bottles and Nozzles

Eye drop packaging affects both safety and patient experience: 

  • Drop size depends on nozzle design and formulation viscosity, affecting dose and comfort. 
  • Squeeze force must suit patients, including elderly users. 
  • Plastic permeability can allow water loss or interaction with preservatives over time. 
  • Preservative-free designs use valves or filters to keep contents sterile after opening. 
  • Tamper evidence reassures patients that the product is unopened. 

Our ophthalmic formulation development work considers packaging and formulation together, because each affects the other. 

Qualifying Packaging Components

Before a container is used commercially, it should be qualified: 

  1. Supplier evaluation and approval. 
  2. Specifications for dimensions, materials and appearance. 
  3. Compatibility assessment with the formulation. 
  4. Extractables and leachables evaluation, where relevant to the product and route. 
  5. Container closure integrity testing to confirm sterility protection. 
  6. Stability studies in the final container. 
  7. Machinability trials on filling and sealing lines. 

This evidence supports regulatory submissions, as described in Module 3 of the CTD dossier, and helps prevent problems after launch. 

Packaging and Regulatory Submissions

Regulators expect a description of the container closure system and evidence of its suitability. This typically includes material details, specifications, compatibility data and stability results. Changing a container or supplier after approval may require notifying or seeking approval from regulators, so getting packaging right early saves time later. Kilitch’s technology transfer and formulation development teams consider these requirements from the start. 

Secondary Packaging and Labelling

Beyond the primary container, cartons, leaflets and labels carry critical information and protect products during distribution. Export markets may require specific languages, pack sizes and serialisation. Hospital and tender supplies may need special labelling. Kilitch coordinates secondary packaging with partners according to market requirements. See our page on pharmaceutical export. 

Extractables and Leachables

Components in contact with a drug can release chemical substances. Extractables are compounds that can be released under aggressive laboratory conditions, while leachables are those that actually migrate into the product under normal storage. For injectables and ophthalmic products, where the product contacts sensitive tissues or enters the bloodstream directly, assessing these substances is especially important. The level of evaluation depends on the route of administration, product composition, contact time and component materials. Supplier data, literature and targeted studies are combined to justify that leachables are within safe limits. 

Sustainability in Packaging

Pharmaceutical brands are increasingly interested in reducing packaging waste. Options can include right-sizing cartons, reducing unnecessary secondary packaging and selecting materials with lower environmental impact. For sterile products, however, any change must not compromise sterility, stability or safety, and may require regulatory review. Kilitch can discuss practical packaging improvements with partners while keeping product protection the first priority. 

Supply Chain Security for Packaging

Packaging components can become bottlenecks. Specialised glass, stoppers, syringes and ophthalmic bottles may have long lead times, limited suppliers or minimum order quantities. A shortage of a single component can stop production even when the drug itself is available. Partners can reduce this risk by qualifying suitable alternative suppliers where possible, maintaining safety stock and sharing forecasts early. Any change of supplier for an approved product should go through change control and regulatory assessment before use. 

Frequently Asked Questions

Should my injectable be in a vial, ampoule or prefilled syringe? 

It depends on dose type, stability, market preference, cost and regulatory factors. We assess options with partners during development. 

Why does stopper selection matter? 

Stoppers can release extractables, affect sterility and influence drying of lyophilised products, so the material must suit the formulation. 

What is container closure integrity? 

It is the ability of the container and closure to keep the product sterile and protected throughout its shelf life. 

Can packaging be changed after approval? 

Changes are possible but may require regulatory notification or approval, so careful initial selection is important. 

Do you support preservative-free eye drop packaging? 

Preservative-free options can be discussed based on product and market needs. 

Get the Packaging Right from the Start

Tell us about your product, intended container and target markets. We will help you select and qualify suitable primary packaging. Contact Kilitch Healthcare or explore our services.